Medpace Holdings, Inc. (MEDP) News
Follow Medpace Holdings, Inc. (MEDP) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 23 public stories across 11 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Medpace Q3'26 Revenue Estimate Is 714.47M USD
Medpace is scheduled to report Q3'26 results on October 21 after the market close. Revenue is estimated at 714.47 million USD and EPS at 4.44 USD.
EQUITY | Oct 14, 2026, 11:01 AM UTC
L
Medpace Holdings President & CEO Sold Shares Worth Over $1.5M
August J. Troendle, a 10% owner and President & CEO, reported sales of Medpace Holdings common stock on September 25 and September 28, 2026. The reported selling prices were a weighted average of $620.6 for one tranche a
EQUITY | Sep 29, 2026, 08:20 PM UTC
L
Medpace Holdings President & CEO Sold Shares Worth Over $27M
August J. Troendle, a 10% owner and President & CEO, sold common stock in two transactions on September 23—24, 2026. The reported prices are weighted averages: $628.64 for the 16,083 shares sold on September 23 and $621.
EQUITY | Sep 25, 2026, 08:33 PM UTC
L
Medpace Holdings President & CEO Sold Shares Worth Over $44M
Troendle August J., a 10% owner and President & CEO, reported sales of common stock effected pursuant to a limit order placed during an open window period. The report states weighted average sale prices of $623.29 for sh
EQUITY | Sep 23, 2026, 08:11 PM UTC
M
Medpace to report Q3 2026 results Oct. 21, 2026
Medpace said it will release its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026, and host a conference call on Thursday, October 22, 2026 at 9:00 a.m. ET.
EQUITY | Sep 22, 2026, 08:05 PM UTC
L
Medpace director sells shares worth over $2.3M
A Medpace director sold shares worth over $2.3M, according to TradingView News.
EQUITY | Aug 28, 2026, 08:42 PM UTC
L
Medpace CEO sold shares worth over $2.8M
Medpace’s President and CEO sold shares worth over $2.8M, according to TradingView News.
EQUITY | Aug 27, 2026, 08:23 PM UTC
H
IQV shares +10% premarket after results and guidance as raises FY2026 adj EPS forecast to $12.80-$13.00 from prior forecast of $12.65-$12.95
IQV shares +10% premarket after results and guidance as raises FY2026 adj EPS forecast to $12.80-$13.00 from prior forecast of $12.65-$12.95as midpoint tops ests $12.90; posted Q2 EPS and rev beat $4.37B vs. est. $4.3B -
EARNINGS | Jul 28, 2026, 12:48 PM UTC
L
MEDP Reiterating Outperform and raising PT to $692 from $484 after results @ RBC
MEDP Reiterating Outperform and raising PT to $692 from $484 after results @ RBC
EQUITY | Jul 24, 2026, 12:01 PM UTC
H
Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook
Medpace Holdings Inc. (NASDAQ: MEDP ) stock is trading higher on Thursday on better-than-expected second-quarter financial results and raised its fiscal 2026 guidance. The clinical contract research organization reported
EARNINGS | Jul 23, 2026, 06:15 PM UTC
H
Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today
U.S. stocks extended their slide on Thursday as Brent crude vaulted above $100 a barrel and the 10-year Treasury yield climbed to an 18-month high, while concerns over Alphabet Inc.’s (NASDAQ: GOOGL ) rising AI capital e
CENTRAL_BANK | Jul 23, 2026, 05:16 PM UTC
L
Largest discount to VWAP QS (-6.31%) ACI (-5.23%) MEDP (-4.53%) MOH (-4.13%) RGEN (-3.89%) LITE (-3.46%) IQV (-3.41%) AUR (-3.37%) CMCSA (-3
Largest discount to VWAP QS (-6.31%) ACI (-5.23%) MEDP (-4.53%) MOH (-4.13%) RGEN (-3.89%) LITE (-3.46%) IQV (-3.41%) AUR (-3.37%) CMCSA (-3.3%) HUBS (-3.25%) (Russell 1000 names)
EQUITY | Jul 23, 2026, 03:42 PM UTC
H
Full Transcript: Medpace Hldgs Q2 2026 Earnings Call
On Thursday, Medpace Hldgs (NASDAQ: MEDP ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our e
EARNINGS | Jul 23, 2026, 02:40 PM UTC
H
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Dow Jones index dipping around 450 points on Thursday. Shares of Lockheed Martin Corp (NYSE: LMT ) rose sharply after the company reported better-than-expected second-quarter financial re
EARNINGS | Jul 23, 2026, 02:20 PM UTC
H
Closing Bell Movers: Tesla, Alphabet slides after earnings
Despite the third consecutive session of gains by Semiconductors, Nasdaq Composite was the worst performing major index, ending the day near session lows below the 25,700 level. Losses among key software names as well as
RATES | Jul 22, 2026, 11:07 PM UTC
L
MEDP +16.8%, RELL +16.3%, URI +10.5%, BDN +4.9%, CSX +4.8%, NOW +4.5%, KALU +4.6%, CSX +4.1%, IBM +2.3%, GGG +2.2%, GOOGL -0.35% after resul
MEDP +16.8%, RELL +16.3%, URI +10.5%, BDN +4.9%, CSX +4.8%, NOW +4.5%, KALU +4.6%, CSX +4.1%, IBM +2.3%, GGG +2.2%, GOOGL -0.35% after results
EQUITY | Jul 22, 2026, 08:40 PM UTC
L
Medpace raises FY26 EPS view to $17.25-$17.95 from $16.68-$17.50
Consensus $17.12. Raises...
EQUITY | Jul 22, 2026, 08:26 PM UTC
L
MEDP Q2 EPS $4.25 vs est $3.97, EBITDA $153.4Mm vs est $147.5Mm on revs $707.3Mm vs est $687.65Mm; guides FY revs $2.805-2.885B vs est $2.77
MEDP Q2 EPS $4.25 vs est $3.97, EBITDA $153.4Mm vs est $147.5Mm on revs $707.3Mm vs est $687.65Mm; guides FY revs $2.805-2.885B vs est $2.778B, EBITDA $618-642Mm vs est $616.6Mm and EPS $17.25-17.95 vs est $16.97; shares
EARNINGS | Jul 22, 2026, 08:23 PM UTC
L
MEDP +16.4%, RELL +12.5%, URI +8.3%, NOW +6.2%, IBM +2.6%, WCN +2.4%, CSX +2.3%, GGG +2.3%, GOOGL flat
MEDP +16.4%, RELL +12.5%, URI +8.3%, NOW +6.2%, IBM +2.6%, WCN +2.4%, CSX +2.3%, GGG +2.3%, GOOGL flat
EQUITY | Jul 22, 2026, 08:22 PM UTC
L
MEDP Medpace RESULTS: Q2, Q2 REV $707.331M vs. EST $687.6M, Q2 Net Income $121.362M
MEDP Medpace RESULTS: Q2, Q2 REV $707.331M vs. EST $687.6M, Q2 Net Income $121.362M
EQUITY | Jul 22, 2026, 08:17 PM UTC
H
Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755
Medpace Holdings (NASDAQ: MEDP ) raises FY2026 GAAP EPS guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 analyst estimate. Raises FY2026 sales outlook from $2.755 billion-$2.855 billion to $2.805 billion-$2.885 bil
EARNINGS | Jul 22, 2026, 08:16 PM UTC
H
Earnings tonight Time, Estimated EPS & Estimated Revenue: 4:00pm LUV $0.49 on $8.57B 4:01pm TXN $1.92 on $5.23B 4:03pm GOOGL $2.87 on $113.6
Earnings tonight Time, Estimated EPS & Estimated Revenue: 4:00pm LUV $0.49 on $8.57B 4:01pm TXN $1.92 on $5.23B 4:03pm GOOGL $2.87 on $113.63B 4:05pm KMI $0.31 on $4.24B ROL $0.34 on $1.1B LVS $0.79 on $3.39B 4:07pm TSLA
EARNINGS | Jul 22, 2026, 07:46 PM UTC
L
Implied EPS movers for tonight: TSLA +/-4.9%, GOOGL +/-3.5%, GOOG +/-4.9%, TXN +/-8.2%, IBM +/-5.5%, NOW +/-11.3%, CSX +/-3.7%, URI +/-5.8%,
Implied EPS movers for tonight: TSLA +/-4.9%, GOOGL +/-3.5%, GOOG +/-4.9%, TXN +/-8.2%, IBM +/-5.5%, NOW +/-11.3%, CSX +/-3.7%, URI +/-5.8%, MOH +/-13.1%, KMI +/-2.4%, CCI +/-7.3%, RJF +/-5.7%, LVS +/-5.8%, AVB +/-4.7%,
EARNINGS | Jul 22, 2026, 06:29 PM UTC